We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Pfizer Inc | NYSE:PFE | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.06 | 0.23% | 25.70 | 3,269 | 09:14:27 |
From Feb 2023 to Feb 2025
By Sabela Ojea
Pfizer said Friday the Food and Drug Administration has approved Litfulo, its oral treatment for alopecia.
The healthcare company said Litfulo can treat patients aged 12 years and older, becoming the only medication approved by the FDA for adolescents with severe alopecia areata.
Write to Sabela Ojea at sabela.ojea@wsj.com
(END) Dow Jones Newswires
June 23, 2023 18:22 ET (22:22 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Pfizer Chart |
1 Month Pfizer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
